Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02053506 · ClinicalTrials.gov registry record · NA
Nutrition Interventions to Support the Immune System in Response to Stress
A NA study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT02053506: Completed NA study, sponsored by United States Army Research Institute of Environmental Medicine.
NCT02053506 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02053506, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
Physical and psychological stress on military personnel during training and operational missions can suppress immune function. Creating superficial skin wounds via suction blisters can be used to detect changes in immune function. The goals of this research are to: 1) identify changes in immune function (blood measures and healing time of skin wounds) in response to sleep restriction; and, 2) test the influence of a multi-nutrient beverage and healthy bacteria (i.e., probiotics) on immune function (blood measures and healing time of skin wounds) in response to sleep restriction.
Primary Outcome
Skin barrier restoration is assessed via transepidermal water loss (TEWL). Skin barrier is considered "restored" when TEWL returns to within 90% of baseline levels.
Interventions
- DIETARY_SUPPLEMENT Immune-enhancing nutritional beverage
- DIETARY_SUPPLEMENT Probiotics (BB-12)
- DIETARY_SUPPLEMENT Placebo (for nutritional beverage and probiotic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02053506 record still lists
NCT02053506 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Immune-enhancing nutritional beverage is the first listed.
NCT02053506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02053506 about?
NCT02053506 is a clinical study titled "Nutrition Interventions to Support the Immune System in Response to Stress". Physical and psychological stress on military personnel during training and operational missions can suppress immune function. Creating superficial skin wounds via suction blisters can be used to detect changes in immune function. The goals of this research are to: 1) identify changes in immune func...
What is the current status of trial NCT02053506?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2014-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02053506?
The interventions under investigation include: Immune-enhancing nutritional beverage (DIETARY_SUPPLEMENT), Probiotics (BB-12) (DIETARY_SUPPLEMENT), Placebo (for nutritional beverage and probiotic) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02053506?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02053506's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia